Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Non-invasive breathing therapies to improve respiratory function after chronic spinal cord injury

Official title: Non-Invasive Interventions and Biomarker Identification for Respiratory Recovery in Chronic Spinal Cord Injury

Run by Thomas Jefferson University · NCT07135583 · Data updated 2026-11-12

We will try combining non-invasive spinal electrical stimulation and brief high-carbon-dioxide breathing with respiratory resistance exercises to see if they improve breathing in adults with chronic incomplete spinal cord injury.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorThomas Jefferson University
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedSeptember 18, 2025
Main results expectedAugust 15, 2027
Study endsAugust 15, 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT07135583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 with chronic (≥1 year) incomplete spinal cord injury at or below C-3 to T-8 who are medically stable, have non-progressive injury, and show greater than 20% impairment in maximal inspiratory or expiratory pressure are the intended participants.

Probably not a fit

People with complete diaphragm paralysis, active cardiovascular or lung disease, uncontrolled autonomic dysreflexia, recent infections or non-healing wounds, pregnancy, seizure disorders, or other listed exclusion conditions are unlikely to be eligible or to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-site, interventional crossover trial tests whether four consecutive days of combined hypercapnic-intermittent hypoxia (HiCO2-AIH) and transcutaneous spinal cord stimulation (tSCS) enhances the effect of respiratory resistance training in adults with chronic incomplete cervical or thoracic SCI. Using a Williams crossover design, up to 20 participants (target n=16 after accounting for dropout) will receive the combined intervention, each single intervention alone, and respiratory resistance exercise alone across separate treatment periods. The primary outcome is change in mouth occlusion pressure at 0.1 seconds (P0.1) measured from before to one day after intervention, with secondary outcomes including maximal inspiratory and expiratory pressures, forced vital capacity, and diaphragm neurophysiology measured by TMS and cervical magnetic stimulation. The study will also collect blood and genetic biomarkers to explore predictors of response and will continuously monitor respiratory and cardiovascular safety parameters during interventions.

Why it matters

Potential benefit: If successful, the approach could strengthen breathing drive and muscle function, reduce respiratory complications, and improve quality of life for people with chronic incomplete SCI.

How similar studies have gone: Prior small studies of intermittent hypoxia and spinal stimulation have shown promise for improving motor and some respiratory outcomes after SCI, but combining HiCO2-AIH with tSCS for respiratory training is novel and not yet established in larger trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. adults 18 to 70 years of age (the latter to reduce likelihood of cardiovascular disease);
2. chronic SCI for ≥ 1 year at or below C-3 to T-8
3. incomplete SCI based on classification of incomplete-B, C or D
4. medically stable with clearance from physician
5. SCI due to non-progressive etiology
6. \>20% impairment in maximal inspiratory or expiratory pressure generation

Exclusion Criteria:

* Individuals will be excluded due to (1) current diagnosis of an additional neurologic condition (eg. multiple sclerosis or stroke) (2) loss of diaphragm EMG activity on forced respiratory tests; (3) severe illness or infection (4) non-healing decubitus ulcers (5) untreated bladder or urinary infections (6) cardiovascular disease (7) lung disease (8) active heterotopic ossification (9) uncontrolled hypertension; (10) severe neuropathic pain; (11) pregnancy (5) severe recurrent and uncontrolled autonomic dysreflexia (6) history of seizure disorder.

Where it's running

  • Thomas Jefferson University Center City Campus
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Jay Nair, PT, PhD — Thomas Jefferson University
  • Study coordinator: Jay Nair, PT, PhD
  • Email: nairlab@jefferson.edu
  • Phone: 13528715888

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.